Back
Crown Castle 10K Form
Sell
31
CCI
Crown Castle
Last Price:
105.41
Seasonality Move:
6.82%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2024-05-01 | 10Q | CCI/Crown Castle Quarterly |
| 2023-11-01 | 10Q | CCI/Crown Castle Quarterly |
| 2023-08-02 | 10Q | CCI/Crown Castle Quarterly |
| 2023-05-03 | 10Q | CCI/Crown Castle Quarterly |
| 2022-11-04 | 10Q | CCI/Crown Castle Quarterly |
| 2022-08-05 | 10Q | CCI/Crown Castle Quarterly |
Receive CCI News And Ratings
See the #1 stock for the next 7 days that we like better than CCI
CCI Financial Statistics
Sales & Book Value
| Annual Sales: | $6.98B |
|---|---|
| Cash Flow: | $402M |
| Price / Cash Flow: | 28.12 |
| Annual Sales: | $12.19 |
| Price / Book: | 8.65 |
Profitability
| EPS (TTM): | 2.82000 |
|---|---|
| Net Income (TTM): | $1.23B |
| Gross Margin: | $5B |
| Return on Equity: | 20.44% |
| Return on Assets: | 3.2% |
Crown Castle Earnings Forecast
Key Crown Castle Financial Ratios
- The Gross Profit Margin over the past 27 years for CCI is 71.64%.
- The Selling, General & Administrative Expenses for CCI have been equal to 10.87% of Gross Profit Margin.
- The Research & Development expenses have been 0.00% of Revenue.
- The Interest Expense is 54.66% of Operating Income.
- The Net Earning history of CCI is 21.52% of Total Revenues.
- Per Share Earnings over the last 27 years have been positive in 15 years.
Crown Castle Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | S&P500 |
|---|---|
| Industry: | Specialized REITs |
| Sector: | Real Estate |
| Current Symbol: | CCI |
| CUSIP: | 22822V |
| Website: | crowncastle.com |
Debt
| Debt-to-Equity Ratio: | 4.54 |
|---|---|
| Current Ratio: | 0.54 |
| Quick Ratio: | 0.36 |
Price-to-Earnings
| Trailing P/E Ratio: | 30.47 |
|---|---|
| Forward P/E Ratio: | 39.6 |
CCI Technical Analysis vs Fundamental Analysis
Sell
31
Crown Castle (CCI)
is a Sell
Is Crown Castle a Buy or a Sell?
-
Crown Castle stock is rated a Sell
The current Crown Castle [CCI] share price is $105.44. The Score for CCI is 31, which is 38% below its historic median score of 50, and infers higher risk than normal.